ALLERGAN, INC. for ALLERGAN, INC.
A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.
Versions of this report
Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.
| Filing | Filed | Amount | Counted |
|---|---|---|---|
| 1st Quarter - Report (this page) | Apr 21, 2008 | $410,000 | Replaced |
| 1st Quarter - Amendment | Apr 21, 2008 | $410,000 | Replaced |
| 1st Quarter - Amendment | Jun 19, 2009 | $400,000 | Yes |
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Trade (domestic/foreign) TRD
HR5629: PATHWAY FOR BIOSIMILAR ACT; ALL ASPECTS OF THE BILL
| Lobbyist | Covered position, as disclosed |
|---|---|
| W BRADFORD GARY | N/A |
Taxation/Internal Revenue Code TAX
HR1712: RESEARCH AND DEVELOPMENT TAX CREDIT ACT OF 2007; ALL ASPECTS OF BILL HR5629: PATHWAY FOR BIOSIMILAR ACT; ALL ASPECTS OF BILL
| Lobbyist | Covered position, as disclosed |
|---|---|
| W BRADFORD GARY | N/A |
Medicare/Medicaid MMM
HR5629: PATHWAY FOR BIOSIMILAR ACT; ALL ASPECTS OF BILL
| Lobbyist | Covered position, as disclosed |
|---|---|
| W BRADFORD GARY | N/A |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.